16 October 2026 Dear Shareholder Cynata Therapeutics Limited – Pro-Rata Renounceable Entitlement O?er As announced on 8 October 2026, Cynata Therapeutics Limited (ACN 104 037 372) (CYP or the Company), is undertaking a pro-rata renounceable entitlement o?er in accordance with the terms of the...